Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Legal Proceedings Report 2020

Jul 20, 2020

59275_rns_2020-07-20_d612cbc6-db26-4da3-8ffc-51cc158a8514.pdf

Legal Proceedings Report

Open in viewer

Opens in your device viewer

20[th] July 2020

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

  • (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Update on Cipla and Amgen reach a settlement on pending litigation involving generic cinacalcet hydrochloride tablets (30mg, 60mg and 90mg)

Dear Sir / Madam,

This is to inform you that the civil action filed by Cipla Limited and Cipla USA Inc, wholly owned step-down subsidiary of Cipla Limited (hereinafter together referred to as “Cipla”) in the U.S. District Court for the District of Delaware in January 2019 has been resolved as between Cipla and Amgen Inc. (hereinafter referred to as “Amgen”). A formal stipulation of dismissal has been filed with the Court and is awaiting signature by the presiding Judge. Cipla’s action pertaining to Teva Pharmaceuticals Inc. remains pending. The resolution entitles Cipla and its affiliates to continue importing, marketing, and selling its generic cinacalcet hydrochloride tablets 30mg, 60mg and 90mg in the United States.

Cinacalcet hydrochloride tablets are indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis, for the treatment of hypercalcemia in adult patients with Parathyroid Carcinoma, and for treatment of severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy.

Kindly acknowledge the receipt.

This is for your information and records.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDRA CHOPRA Digitally signed by RAJENDRA CHOPRA DN: c=IN, o=Personal, 2.5.4.20=4987ad48c3965cfde78c8ea69e6f40ac91535876f12ba1fa5ba45cc5cc8db6cb, postalCode=122001, st=HARYANA, serialNumber=0be85c0408d0e3afd663669f5314248a72fdcdf34d01d48d472d7cf9262696f6, cn=RAJENDRA CHOPRA Date: 2020.07.20 09:17:48 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Juzer Masta